Tonic-Clonic Seizure in a Liver-Transplant Recipient due to Concomitant Use of Colchicine with Cyclosporine A and Valganciclovir
Journal of Infectious Diseases & Travel Medicine · 2018
DOI: 10.23880/jidtm-16000108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Infectious Diseases & Travel Medicine, 2018. Verfasst von Iris Wai Sum L.
Abstract (Originalsprache)
Use of immunosuppressant was inevitable in post-transplant recipients for prevention and treatment of allograft rejection.Concomitant use of antivirals in prevention of Cytomegalovirus disease after transplantation were common; and reduction in acute allograft rejection and all-cause mortality had also been shown.However, adverse effects from potential interactions between immunosuppressants and antiviral would have been overlooked easily; especially when adverse effects were further potentiated by addition of other medications for trivial conditions.Colchicine was commonly prescribed for clinical gout that occurred at higher incidences in post-transplant recipients on cyclosporine A or tacrolimus.We reported a post-LT patient developed his first tonic-clonic seizure from concomitant use of colchicine with CSA and valganciclovir.
Zitieren
APA
L, I. W. S. (2018). Tonic-Clonic Seizure in a Liver-Transplant Recipient due to Concomitant Use of Colchicine with Cyclosporine A and Valganciclovir. Journal of Infectious Diseases & Travel Medicine. https://doi.org/10.23880/jidtm-16000108
Vancouver
L IWS. Tonic-Clonic Seizure in a Liver-Transplant Recipient due to Concomitant Use of Colchicine with Cyclosporine A and Valganciclovir. Journal of Infectious Diseases & Travel Medicine. 2018. doi:10.23880/jidtm-16000108
BibTeX
@article{L2018,
author = {L, Iris Wai Sum},
title = {Tonic-Clonic Seizure in a Liver-Transplant Recipient due to Concomitant Use of Colchicine with Cyclosporine A and Valganciclovir},
journal = {Journal of Infectious Diseases & Travel Medicine},
year = {2018},
doi = {10.23880/jidtm-16000108}
}
EUVIMED